VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
BLX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
BLXBladex, Inc.
$55.25$1.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. BLX
  4. Financial Ratios

Bladex, Inc. (BLX) Financial Ratios

Latest Ratios: P/E Ratio 9.0x · EV/EBITDA 16.9x · ROE 15.0%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

BLX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$1.6B$1.7B$1.3B$903M$588M$644M$628M$846M$684M$1.1B$1.2B
Enterprise Value$3.8B$3.9B$3.9B$3.5B$4.1B$3.1B$1.8B$2.8B$2.5B$2.6B$3.3B
P/E Ratio →9.047.306.355.446.3810.259.899.8561.7912.9313.26
P/S Ratio——4.593.804.026.346.306.769.948.218.69
P/B Ratio1.220.990.980.750.550.650.600.830.691.011.14
P/FCF4.284.47—0.85——0.50——1.491.49
P/OCF4.254.43—0.85——0.50——1.481.47

P/E links to full P/E history page with 30-year chart

BLX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue——13.7914.8927.9230.9017.6622.4136.2720.1625.08
EV / EBITDA16.9417.2418.7520.8843.0647.4525.9031.32183.6330.7737.38
EV / EBIT16.9417.2419.0821.2744.3350.0927.6732.61224.1631.6838.27
EV / FCF—10.55—3.33——1.41——3.664.29

BLX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin-201.4%-201.4%100.0%88.4%86.6%100.0%100.0%100.0%100.0%92.3%73.6%
Operating Margin-143.9%-143.9%72.3%70.0%63.0%61.7%63.8%68.7%16.2%63.6%65.5%
Net Profit Margin-143.9%-143.9%72.3%70.0%63.0%61.7%63.8%68.7%16.2%63.6%65.5%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE15.0%15.0%16.2%14.6%8.9%6.2%6.2%8.6%1.1%8.0%8.8%
ROA1.8%1.8%1.8%1.7%1.1%0.9%0.9%1.2%0.2%1.2%1.1%
ROIC2.9%2.9%2.6%2.1%1.3%1.2%1.3%1.5%0.2%1.6%1.4%
ROCE2.7%2.7%4.8%4.3%2.8%2.2%1.5%2.1%0.5%3.2%3.0%

BLX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity2.492.493.433.894.433.781.923.093.582.123.21
Debt / EBITDA18.4218.4221.8927.6449.9656.6529.3835.02261.7126.2036.43
Net Debt / Equity—1.341.962.193.272.521.091.931.821.482.15
Net Debt / EBITDA9.949.9412.5115.5536.8537.7216.6621.87133.3218.2424.43
Debt / FCF—6.08—2.48——0.91——2.172.80
Interest Coverage0.460.460.390.370.501.160.720.520.070.770.96

BLX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio14.7514.750.300.330.230.250.250.760.360.180.26
Quick Ratio14.7514.750.300.330.230.250.250.760.360.180.26
Cash Ratio14.7414.740.270.310.210.250.240.730.340.170.25
Asset Turnover—-0.010.020.020.020.010.020.020.010.020.02
Inventory Turnover———————————
Days Sales Outstanding———————————

BLX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield4.5%5.5%5.6%4.0%6.1%6.0%7.1%7.0%9.0%5.7%5.2%
Payout Ratio40.5%40.5%35.4%21.8%39.3%61.5%70.2%68.4%552.5%73.9%69.1%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield11.1%13.7%15.7%18.4%15.7%9.8%10.1%10.1%1.6%7.7%7.5%
FCF Yield23.4%22.4%—117.4%——198.3%——67.1%67.3%
Buyback Yield0.0%0.0%0.0%0.0%0.0%9.3%0.0%0.0%0.4%0.0%0.0%
Total Shareholder Yield4.5%5.5%5.6%4.0%6.1%15.3%7.1%7.0%9.4%5.7%5.2%
Shares Outstanding—$37M$37M$36M$36M$39M$40M$40M$40M$39M$39M

Key Metrics

Growth RegimeMixed
ProfitabilityStable
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Revenue volatility and negative fee income

Discount Valuation Masks Franchise Value

Trading at 1.18x book and 8.7x trailing earnings, BLX's multiples sit below regional peers like CIB at 1.75x book, implying the market prices in a sovereign risk discount despite its preferred creditor status.

The P/B of 1.18x is at a premium to Argentine peers (BBAR 1.22x, BMA 1.33x) but a discount to higher-ROE franchises like CIB (1.75x) and BSAC (2.61x). Given a trailing ROE of only 3.8%, the market appears to assign limited growth premium, consistent with a commodity balance sheet rather than a franchise. The forward P/E of 7.99x suggests expectations of modest earnings recovery, but the negative fee income and provision reversals in 2026Q2 raise questions about earnings quality.

ROE Depressed by Low Leverage and Fee Drag

ROE of 3.8% in 2026Q2, per reported figures, is held back by a 12% equity-to-assets ratio and negative fee income of -$160.5M, which offset a doubling NIM to 1.0%.

DuPont decomposition shows that while NIM improved to 1.0% in 2026Q2, the negative non-interest income contribution (-71.4% of revenue) and a conservative leverage ratio (12.5% equity/assets) cap ROE. The bank's high equity buffer, while prudent, dilutes returns; if management deployed excess capital into higher-yielding assets or returned it via buybacks, ROE could improve. However, the sharp revenue decline (-58% YoY) suggests the loan book is contracting, limiting near-term earnings power.

NIM Doubles but Efficiency Ratio Spikes

NIM expanded to 1.0% in 2026Q2 from 0.5% a year earlier, according to financial statements, yet the efficiency ratio deteriorated to 10.6% as non-interest expenses stayed flat while total revenue fell.

The NIM improvement likely reflects higher yields on floating-rate assets in a rising rate environment, but the efficiency ratio spike indicates that the revenue base is shrinking faster than costs. The negative fee income of -$160.5M in 2026Q2 is a major drag, suggesting trading losses or hedging ineffectiveness. Investors should monitor whether the NIM expansion is sustainable given the contracting loan book and the transition from LIBOR to SOFR, which could cause repricing mismatches.

Equity Buffer Strengthens, ROE Sacrificed

Equity/assets improved to 12.5% in 2026Q2 from 11.3% a year earlier, per balance sheet data, reflecting retained earnings and a shrinking loan book, but this conservative leverage depresses ROE.

The bank's capital position appears robust, with equity growing 38.5% YoY to $1.8B, partly due to reduced risk-weighted assets. While this provides a strong buffer against regional volatility, it also means the bank is under-leveraged relative to peers (D/E of 2.49 vs. BBAR's 0.55). The high dividend yield of 4.6% suggests management is returning capital, but the absence of buybacks and the low leverage indicate a lack of high-return deployment opportunities. If the loan book continues to contract, capital ratios could rise further, pressuring ROE.

Provision Reversals Signal Portfolio Shrinkage

Loan loss provisions turned negative at -$107.1M in 2026Q2, per reported figures, suggesting either improving credit quality or a deliberate reduction in the loan book, which aligns with the -58% revenue decline.

The negative provision expense boosted net income, but it may indicate that the bank is shrinking its loan portfolio rather than experiencing a genuine improvement in credit quality. Given the bank's focus on short-term trade finance, a contraction in trade volumes could be driving this. The high net margin of 66.8% implies the remaining book is profitable, but investors should watch for signs of credit deterioration in key markets like Brazil and Mexico, which could reverse these reversals.

P/E Misleads Due to Provision Volatility

The P/E of 8.74x is distorted by provision reversals and negative fee income in 2026Q2, which artificially boosted earnings; a more reliable metric is P/B at 1.18x, which reflects the bank's tangible book value.

For banks, P/E is often misapplied because provisions can swing earnings dramatically, as seen in 2026Q2 when negative provisions of $107.1M inflated net income. The trailing P/E of 8.74x may understate the bank's true earnings power if provisions normalize. Instead, investors should focus on P/B and ROTCE, which are less volatile. The P/B of 1.18x suggests the market is pricing in a modest premium to book, but given the low ROE, this premium may be justified by the bank's unique preferred creditor status and stable dividend.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus & Technical Research Suite
Open BLX Terminal

BLX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BLX — Frequently Asked Questions

Quick answers to the most common questions about buying BLX stock.

What is Bladex, Inc.'s P/E ratio?

Bladex, Inc.'s current P/E ratio is 9.0x. The historical average is 10.9x. This places it at the 46th percentile of its historical range.

What is Bladex, Inc.'s EV/EBITDA?

Bladex, Inc.'s current EV/EBITDA is 16.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 35.5x.

What is Bladex, Inc.'s ROE?

Bladex, Inc.'s return on equity (ROE) is 15.0%. The historical average is 9.0%.

Is BLX stock overvalued?

Based on historical data, Bladex, Inc. is trading at a P/E of 9.0x. This is at the 46th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What is Bladex, Inc.'s dividend yield?

Bladex, Inc.'s current dividend yield is 4.48% with a payout ratio of 40.5%.

What are Bladex, Inc.'s profit margins?

Bladex, Inc. has -201.4% gross margin and -143.9% operating margin.

How much debt does Bladex, Inc. have?

Bladex, Inc.'s Debt/EBITDA ratio is 18.4x, indicating high leverage. A ratio above 4x may signal elevated financial risk.